Dyslipidemia Drug Indications
Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.
Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.
Blood pressure classification, diagnostic workup of hypertension, assess for major cardiovascular disease risk factors and identifiable causes, and blood pressure measurement techniques.
Oral calcium channel blockers (CCBs) for the treatment of hypertension including benzothiazepines, dihydropyridines, and diphenylalkylamines.
Anticoagulants, antiplatelets, and thrombolytics for the treatment and/or prophylaxis of venous and arterial thrombosis.
A comparative list of loop, potassium-sparing, and thiazide-like diuretics monotherapy and combination therapy for the treatment of hypertension.
A comparative list of Angiotensin II Receptor Blockers (ARBs) monotherapy and combination therapy for the treatment of hypertension.
Recommended dosing conversions for anticoagulants such as warfarin, heparin, and dabigatran.
Researchers sought to determine the accuracy of established tools in predicting the risk of cardiovascular events in patients with CML receiving TKIs.
In a study of men with prostate cancer, the presence of pre-existing cardiovascular diseases was associated with higher risk of death from taking certain medications.
Risk for coronary artery disease significantly decreased for survivors with diagnosis in 80s, 90s versus 70s.